Like most small public companies, Abiomed Corp., a $73 million medical device maker, must meet all the same Sarbanes-Oxley internal control compliance requirements as most large public companies—but with quite fewer resources.

Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
Like most small public companies, Abiomed Corp., a $73 million medical device maker, must meet all the same Sarbanes-Oxley internal control compliance requirements as most large public companies—but with quite fewer resources.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger
We'll send a verification code to %EMAIL%.